Related Experiment Videos
Hypertension in the elderly
1Department of Geriatrics, La Grange Memorial Hospital, IL 60525, USA.
Insights
Systolic hypertension poses a greater cardiovascular risk than diastolic hypertension. Treating isolated systolic hypertension, even in older adults, significantly lowers cardiovascular event rates.
Area of Science:
- Cardiology
- Geriatrics
- Public Health
Background:
- Systolic blood pressure (SBP) elevation is a critical cardiovascular disease (CVD) risk factor.
- Isolated systolic hypertension (ISH) management is crucial, particularly in the elderly.
Purpose of the Study:
- To evaluate the significance of systolic versus diastolic blood pressure in CVD risk.
- To assess the impact of ISH treatment on cardiovascular outcomes.
- To provide guidance on managing hypertension in various patient populations, including the elderly.
Main Methods:
- Comparative analysis of SBP and diastolic blood pressure (DBP) as CVD risk factors.
- Review of studies on the efficacy of ISH treatment in reducing fatal and nonfatal cardiovascular events.
- Evaluation of treatment strategies, including non-pharmacologic measures, behavior modification, and pharmacotherapy.
Main Results:
- SBP > 160 mm Hg is a more significant CVD risk factor than DBP > 95 mm Hg, irrespective of age.
- ISH treatment demonstrably reduces cardiovascular events, including in patients over 80.
- Non-pharmacologic interventions are recommended for 3-6 months for mild hypertension; medication may be needed sooner for high-risk individuals.
- Initial medication doses for frail elderly should be halved.
- Long-acting diuretics or beta-blockers are preferred first-line agents; ACE inhibitors and calcium channel blockers lack proven mortality benefits in uncomplicated hypertension but may help specific comorbidities.
Conclusions:
- Systolic hypertension is a primary target for CVD prevention.
- Effective management of ISH, including in advanced age, improves cardiovascular outcomes.
- Treatment strategies should be individualized based on blood pressure levels, comorbidities, and patient frailty.
Abstract:
A systolic blood pressure greater than 160 mm Hg is a more significant risk factor for cardiovascular disease than a diastolic blood pressure greater than 95 mm Hg, regardless of a patient's age. Treatment of isolated systolic hypertension significantly reduces the incidence of both fatal and nonfatal cardiovascular events, even in patients who are over 80 years of age. Non-pharmacologic measures and behavior modification should be tried for three to six months in a patient with mildly elevated blood pressure (140 to 160 mm Hg/90 to 100 mm Hg). If these measures fail or the patient has target-organ disease or multiple cardiac risk factors, medication may be prescribed earlier. Half the usual recommended dose should be initially prescribed in the frail elderly. Long-acting diuretics or beta blockers are recommended first-line agents. Angiotensin-converting enzyme inhibitors, calcium channel blockers and alpha blockers have not been shown to reduce mortality in hypertensive patients who do not have comorbid disease. Angiotensin-converting enzyme inhibitors may benefit hypertensive patients with heart failure, and calcium channel blockers may help those with angina, especially vasospastic angina.